Post-transcriptional modification mapping in the Clostridium acetobutylicum 16S rRNA by mass spectrometry and reverse transcriptase assays by Emmerechts, Gert et al.
3494–3503 Nucleic Acids Research, 2007, Vol. 35, No. 10 Published online 3 May 2007
doi:10.1093/nar/gkm248
Post-transcriptional modification mapping in the
Clostridium acetobutylicum 16S rRNA by mass
spectrometry and reverse transcriptase assays
Gert Emmerechts
1,*, Sofie Barbe ´
2, Piet Herdewijn
1, Jozef Anne ´
2 and Jef Rozenski
1
1Laboratory for Medicinal Chemistry and
2Laboratory of Bacteriology, Rega Institute for Medical Research,
Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
Received January 18, 2007; Revised and Accepted April 5, 2007
ABSTRACT
Post-transcriptional modifications in ribosomal
RNA are believed to fine-tune the RNA
functions. The present study describes the char-
acterization of the post-transcriptional modifica-
tions in Clostridium acetobutylicum 16S rRNA,
using high-pressure liquid chromatography
(HPLC) coupled to electrospray ionization mass
spectrometry and reverse transcriptase assays.
The combination of these techniques allowed
the identification of eleven modified nucleosides,
which were mapped onto the rRNA sequence.
The C. acetobutylicum modification map is similar
to that of Escherichia coli, with the majority of the
modifications near functionally important sites in
the rRNA. Although, in general, the number
of modifications in rRNA is smaller than in tRNA,
the conservation of the modification sites seems to
indicate that the post-transcriptional modifications
in 16S rRNA provide a necessary prerequisite for the
ribosomal function.
INTRODUCTION
One of the most intriguing aspects of non-coding RNAs
(ncRNAs) is their post-transcriptional modiﬁcation. Post-
transcriptional modiﬁcations in RNAs are of three main
types (1): (i) conversion of uridine to pseudouridine
(5-ribosyluracil,  ); (ii) methylation of 20 hydroxyls (Nm)
and (iii) alterations to bases, generally methylations
of diﬀerent positions (mN). High-pressure liquid chroma-
tography (HPLC) coupled to mass spectrometry (MS)
is the ﬁrst method of choice for the analysis of
post-transcriptional modiﬁcations because it is both
very sensitive and speciﬁc. Furthermore, nearly all
modiﬁcations cause a change in mass, making detection
with LC/MS fairly straightforward.
Up till now, post-transcriptional modiﬁcations have
been studied mostly in tRNA and oligonucleotide models
(2–4). On the other hand, 16S rRNA is much less
investigated and consequently, the number of organisms
for which the post-transcriptional modiﬁcations in the 16S
rRNA are characterized is much smaller (5). Escherichia
coli is the only mesophilic bacterium for which the rRNA
(16S and 23S) appears to be fully characterized (6)
and recently, the 16S rRNA modiﬁcation map of
Thermus thermophilus was published (7).
The collective importance of post-transcriptional
modiﬁcations for eﬃcient protein synthesis has been
demonstrated by the superior performance of authentic
rRNAs compared to unmodiﬁed 16S rRNA (8) and
23S rRNA (9) counterparts. Further analysis of
the function of post-transcriptional modiﬁcations in
16S rRNA would most deﬁnitely beneﬁt from a
larger number of fully characterized organisms to allow
comparison of the data (5). As a ﬁrst step in
the production of these data, we analyzed the
C. acetobutylicum 16S rRNA. Clostridium acetobutylicum
was selected in order to add a Gram-positive, anaerobic
and mesophilic bacterium to the short list of bacteria for
which the 16S rRNA modiﬁcation map has been
completed (5). Furthermore, the rather low-G content of
the C. acetobutylicum 16S rRNA (30%) leads to larger
oligonucleotides when the rRNA is hydrolyzed with the
G-speciﬁc endonuclease T1 and this facilitates the
localization of modiﬁcations.
At ﬁrst, modiﬁed nucleosides were identiﬁed solely
based on their chromatographic mobility (e.g.
32P and/or
14C-labeling and 2D electrophoresis combined with
thin layer chromatography (TLC), anion exchange
chromatography and HPLC). However, these methods
suﬀer from poor speciﬁcity and reproducibility and
identiﬁcation becomes problematic as the number of
modiﬁcations or RNA chain length increases. In contrast,
MS is a better technique for the analysis of
post-transcriptional modiﬁcations, because nearly all
modiﬁcations produce a change in mass of the canonical
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has long been restricted due to the experimental diﬃculties
associated with the ionization of polar compounds such as
nucleosides, nucleotides and oligonucleotides. Since
the development of electrospray ionization (ESI) and
matrix-assisted laser desorption ionization (MALDI),
these molecules can be ionized and analyzed by MS. ESI
currently holds the advantage because of its greater
accuracy and ease with which it can be coupled to
chromatographic separation systems. Combining the
high-resolving power of the HPLC system and the high
speciﬁcity of the mass measurement oﬀers a method which
is superior to either method alone (10). More than a
hundred diﬀerent modiﬁcations are known (11) and the
majority have been characterized by some form of MS.
The general setup for identiﬁcation and sequence
placement of post-transcriptional modiﬁcations in large
RNAs is based on the LC/ESI-MS analysis of two
enzymatic digests. First the rRNA strand is digested
to the nucleoside-level and analyzed by LC/ESI-MS.
The combination of chromatographic retention times
and mass measurements allows identiﬁcation of nearly
all the modiﬁcations that are present in the original intact
RNA strand. Distinction between isomers (e.g. m
5C and
m
4C) is made based on comparison to tandem MS
(pseudo MS
3, see the Methods section) analysis of
reference samples. In a second step, sequence-speciﬁc
endonucleases are used to cleave the intact RNA at
speciﬁc positions (e.g. RNase T1 cleaves the 30-side of
all unmodiﬁed guanosines and RNase A cleaves at the
30 end of all pyrimidine nucleotides). This way,
oligonucleotides restricted to one or two 30-nucleotide
types are produced, which are subsequently analyzed
by LC/ESI-MS. Comparison of the observed mass data
with data predicted from the gene sequence identiﬁes
oligonucleotides that contain modiﬁcations. These anom-
alous oligonucleotides are analyzed by MS/MS for exact
sequence placement of the modiﬁcation in the oligonu-
cleotide and thus in the RNA sequence. Two types of
MS/MS experiments were used: In a ﬁrst condition
without precursor selection in the quadrupole, a higher
collision energy is used to release monomer ions from the
oligonucleotide. These monomers are often base ions, but
also nucleoside phosphates and cyclic phosphates can be
used. The Time-of-Flight (TOF) analyzer screens both
the low-mass region for the modiﬁed monomer and the
high-mass region for the intact oligonucleotide.
Corresponding signals in the reconstructed ion
chromatograms (RICs) identify the nature of the modi-
ﬁcation in the oligonucleotide. In a second condition, MS/
MS analysis, with precursor selection, is used for
sequencing of the oligonucleotide and exact sequence
placement of the modiﬁcation that was identiﬁed in the
base-release experiments.
Using LC/ESI-MS nearly all the post-transcriptional
modiﬁcations can be mapped in the RNA sequence.
Pseudouridine, however, does not allow straightforward
analysis by MS because it is isobaric to the omnipresent
uridine. Patteson et al. (12) and Mengel-Jo ¨ rgenson et al.
(13) reported addition of a mass tag to all   by
speciﬁc derivatization. We developed a method to increase
  detection sensitivity by derivatization with methyl vinyl
sulfone (14). Pomerantz and McCloskey identiﬁed
  solely based on identiﬁcation of signature masses for
  (15). Unfortunately, the presence of   in the sequence
G G (as in the case of C. acetobutylicum 16S rRNA)
makes these methods not useful because they are all based
on preliminary RNase T1 digestion, which will produce
numerous UG isomers. Pomerantz and McCloskey
propose in this case to replace RNase T1 by nuclease
U2, but this enzyme is no longer commercially available.
Therefore, a reverse transcriptase assay was used
for placement of pseudouridines in the 16S rRNA
sequence. Pseudouridine bases were selectively derivatized
with N-cyclohexyl-N0-b-(4-methylmorpholinium) ethylcar-
bodiimide p-tosylate (CMCT). Upon subsequent reverse
transcription, CMC derivatized   blocks elongation of
radioactively labeled primers, highlighting the position
of the   on a PAGE gel (16–18).
Even without CMC derivatization, the reverse
transcriptase approach can be used for sequence
conﬁrmation of modiﬁcations found by LC-MS, because
most modiﬁcations block the reverse transcriptase elonga-
tion. Therefore, reverse transcriptase assays can be used to
determine the sequence location of modiﬁcations when
this is not possible by LC-MS analysis. Examples are the
identiﬁcation of a modiﬁed oligonucleotide in a group
of isomers or when problems arise during MS/MS
sequencing (for examples, see the result section below).
In any case, the reverse transcriptase stops should be
checked by simultaneous analysis of in vitro transcribed
RNA, because stops can be caused by secondary structure
of the RNA, even at elevated temperatures (18,19).
MATERIALS AND METHODS
Cells
Clostridium acetobutylicum (ATCC824) was grown in
2 YT medium containing 16g bacto-tryptone, 10g
yeast extract, 4g NaCl and 10g glucose per liter.
Cultures were grown anaerobically in a modular
atmosphere-controlled system (MACS, Don Whitley
Scientiﬁc, Shipley, UK) at 378C in 50ml medium.
Growth phase was monitored by turbidity measurement
at 600nm and cells were harvested at an OD of  1.5 by
centrifugation at 10000 r.p.m. for 10min. Multiple
isolates of these 50ml batches were combined and pellets
were stored at  808C.
Isolationof rRNA
16S rRNA was isolated in two steps. A ﬁrst step consisted
of the isolation of total RNA from the bacterial pellet
using lysozyme digestion and phenol/chloroform extrac-
tion. In a second step, the 16S rRNA was puriﬁed from
this total RNA mixture by rate zonal centrifugation
through a 10–30% sucrose gradient. The samples were
centrifuged at 94 000g on a Beckman L7-55 ultracentri-
fuge (SW 28 rotor) for 24h, and 750ml fractions were
collected.
Purity of the isolated 16S rRNA was assessed
by formaldehyde-agarose gel electrophoresis
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Enzymatic digestion ofrRNA
To produce the nucleoside mixture, 100mg( 3 mg/ml) 16S
rRNA was hydrolyzed with 10 U nuclease P1 (Amersham,
Chalfont, UK), 0.01 U snake venom phosphodiesterase I
(E.C.3.1.15.1, Sigma, St. Louis, MO, USA), and 2.5 U
shrimp alkaline phosphatase (E.C. 3.1.3.1., Amersham) as
described by Crain (20). Digests were stored at  808C
until analysis by LC/ESI-MS.
To produce the oligonucleotide mixture, 100mg 16S
rRNA (10mg/ml in 10mM Tris–HCl, 1mM EDTA acid,
pH 7.4) was hydrolyzed with RNase T1 (E.C. 31.27.3,
Amersham-GE Healthcare) at 378C for 30min.
The amount of enzyme was 1 U RNase T1/3mg rRNA
and digests were also stored at –808C until analysis by
LC/ESI-MS. With these conditions, m
2
2G and m
7G
modiﬁcations were resistant to RNase T1 hydrolysis.
LC/ESI-MS ofthe nucleosides
The instrument used for all studies was an orthogonal
acceleration quadrupole time of ﬂight, oa-qTOF (Q-Tof 2
Micromass, Manchester, UK), with an ESI source,
interfaced to a capillary liquid chromatograph with
a diode array detector (Waters, Milford, MA, USA).
Both the mass spectrometer and the CapLC are
controlled by the MassLynx 3.4 software (Micromass,
Manchester, UK).
For the nucleosides mixture, 2–5 pmol of rRNA
hydrolysate were injected directly onto an Atlantis dC18
column (0.32 150mm, 3mm diameter particles, Waters,
Milford, USA). The column was eluted at a ﬂow rate of
5ml/min using an ammonium acetate (50mM in Millipore
Milli-Q water, pH 6.0)/acetonitrile gradient (21).
Diode array UV absorbance data were acquired from
240–300nm.
The chromatographic eﬄuent was conducted without
splitting into the mass spectrometer and two diﬀerent scan
functions were used. For the ﬁrst scan function, the cone
voltage and collision energy were set to 30V and 10eV,
respectively, allowing mass measurement of the intact
nucleoside. Qualitative interpretation of data was carried
out as previously described (21). Data were acquired over
a mass range of m/z 100–700. For the second scan
function, pseudo MS
3 was accomplished by fragmentation
in the source, selection of the base anion in the quadrupole
and fragmentation in the collision cell. The cone voltage
used for MS
3 was 30–40V and the collision energy 30eV.
Data were acquired in positive mode over a mass range of
m/z 50–250. With this second scan function, distinction
between nucleoside isomers (e.g. m
5C and m
4C) is
possible.
The capillary voltage for both scan functions was 3kV,
and data were acquired in continuum mode during 1.9s
(with 0.1s interscan delay, giving a cycle time of 2s).
LC/ESI-MS ofan oligonucleotides mixture
The same instruments were used as for the analysis of the
nucleoside mixture. 2–5 pmol of the oligonucleotide
mixture were injected directly onto a PepMap
C18 column (0.3 150mm, 5mm-diameter particles,
LC-Packings, Amsterdam, The Netherlands).
The column was eluted at a ﬂow rate of 5ml/min, using
a 1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFiP, Acros, Geel,
Belgium) based solvent system (60mM HFiP in MQ
water, adjusted to pH 7.5 with triethylamine) (22). The
organic modiﬁer was acetonitrile and a 2-step linear
gradient (0.5%/min during 50min and 5%/min during
10min.) was used. Diode array UV absorbance data were
acquired from 230 to 320nm.
Diﬀerent scan functions were used for data acquisition.
During the ﬁrst scan function, cone voltage and collision
energy were kept at 30 and 10eV, respectively.
Thus, minimizing fragmentation, intact oligonucleotide
molecular masses can be detected. Data were recorded in
continuum mode over a m/z 500–1500 mass range. For the
second scan function, the collision energy was increased to
40eV to release monomers from oligonucleotides. Data
were acquired over a m/z 100–1500 mass range and
modiﬁed bases and intact precursor ions (the modiﬁcation
containing oligonucleotides) are recorded simultaneously.
Oligonucleotide sequencing was performed in a third scan
function at 30V cone voltage and collision energies
varying from 20 to 40eV. During this scan function,
precursor ions were selected in the quadrupole. Finally, to
conﬁrm the detection of sugar methylated nucleosides, a
fourth scan function was used: The cone voltage was
increased to 60V in order to release modiﬁed nucleoside
cyclic phosphate ions. After selection of these ions in the
quadrupole, a collision energy of 20eV was used to release
the unmodiﬁed base and the methylated ribose ion
(pseudo MS
3).
During all scan functions, samples were recorded
in negative mode and the capillary voltage was kept
at  2850V.
Software
Mongo Oligo Mass Calculator (http://medlib.med.utah.
edu/massspec/mongo.htm) generated a mass-ordered list
of all oligonucleotides produced by RNase T1 digestion of
16S rRNA of C. acetobutylicum. This list is calculated
based on the gene sequence (GenBank accession number
NC_003030) and the software allows calculation of the
electrospray series and the selection of modiﬁed
nucleosides.
In-house software was used to search the
C. acetobutylicum 16S rRNA sequence for oligonucleo-
tides corresponding to masses that were found in the mass
data from the samples analyzed. It allows the user to
restrict the search on the basis of the 50 or 30 end, number
and residue masses of modiﬁcations, undercut residues
and phosphorylation state.
Simple oligonucleotide sequencer (SOS) was used for
the sequencing of modiﬁed oligonucleotides based on the
fragmentation spectra produced by CID (23).
In vitro production of16SrRNA
The gene sequence corresponding to C. acetobutylicum
16S rRNA was isolated from genomic DNA
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GCTCAG-30 and primer 1492r: 50-GGCTACCTTGTT
ACGACT-30 (Sigma Genosys). For this PCR, a mixture
of 10:1 Taq: Pfu Turbo polymerases was used and primer
concentrations were 0.5mM. Buﬀer conditions were as
provided by the TOPO cloning protocol. After 3min at
948C, 20 cycles of 1min at 948C, 1min at 558C and 3min
incubation at 728C were used. Incubation of the samples
for 7min at 728C guaranteed full-length PCR products
with 30-A overhangs, necessary for TOPO cloning. After
puriﬁcation with a PCR puriﬁcation kit (Qiagen, Crawley,
UK), the ampliﬁed 16S rRNA gene was cloned, down-
stream of the T7 promotor sequence, into a pCR4-TOPO
vector (Invitrogen, Carlsbad, CA, USA) following the
protocol provide by the supplier. After heat shock
transformation of TOP10 cells, distinct colonies were
incubated overnight in 0.01% ampicillin containing LB.
For the selection of colonies with inserts in the correct
direction, PCR was performed with two combinations of
primers. For a ﬁrst PCR (the positive control), these
primers were 27f (sequence as above) and M13r:
50-GGAAACAGCTATGACCATG-30. If the insert is in
the correct position, a band should be visible at 1.6 kB
after agarose gel electrophoresis. A second PCR (negative
control) with primers 27f and M13f: 50-GTAAAACGA
CGGCCAGT-30 was used for conﬁrmation. If the insert is
in the correct position, no band should be visible after
agarose gel electrophoresis. Conditions were as above,
except that primer concentrations were 0.25mM and no
ﬁnal 7-min incubation step at 728C was necessary. Correct
clones were digested with PmeI, which produces blunt
ends downstream of the rRNA sequence. After cleanup
with a PCR puriﬁcation kit (Qiagen), in vitro RNA was
produced using the Ribomax T7 kit (Promega, Madison,
WI, USA). After RNeasy Mini Kit (Qiagen) puriﬁcation,
1–2mg/ml 16S rRNA was obtained.
CMC derivatization andreverse transcription
Fifteen to twenty-ﬁve microgram of total RNA was
derivatized as in ref. (17). To remove the CMC groups of
U and G, the mixture was placed for 4.5h at pH 10.4 on
378C. After precipitation with sodium acetate and ethanol
the RNA was reverse transcribed with Avian
Myeloblastosis Virus (AMV) reverse transcriptase
(GE Healthcare, Brick, NJ, USA) using 50-
33P-labeled
primers. The primer complementary to residues 548–569
(E. coli numbering) was used for identiﬁcation of  -516.
Other primers used for  -screening were complementary
to residues 1098–1219, 1221–1243, 1435–1475 and
1492–1510. For hybridization, the mixture containing
6 pmol RNA, 0.3 pmol primer and hybridization buﬀer
(55.5mM HEPES Potassium salt pH 7.0 and KCl
111mM) in a total volume of 13.5ml was heated at 808C
for 2min and cooled gradually to 408C in 30min.
For the extension reaction, 1ml hybridization mixture
and 1ml 100mM ddNTP were added to 3ml extension mix
containing: 0.166mM Tris–HCl pH 8.4, 13.3mM MgCl2,
13.3mM DTT, 0.066mM each dGTP, dATP, dCTP and
dTTP (GE Healthcare) and 0.33 U AMV reverse
transcriptase. Samples were incubated 5min at room
temperature and 35min at 428C. After reaction and
precipitation with sodium acetate and ethanol, the
samples were dissolved in 6ml urea loading buﬀer
containing 8M urea, 20mM Tris–HCl pH 7.8, 1mM
EDTA and 0.02% xylene cyanol and bromophenol blue
dyes. The samples were loaded on 7M urea  8%
polyacrylamide gels and run in 1  TBE buﬀer at 45W
until the bromophenol blue dye reached the bottom of the
gel. Radioactive products were visualized using a
PhosphorImager.
Except for the CMC derivatization, sequence location
of m
5C at position 1409 (E. coli numbering) was
performed by reverse transcription of radiolabeled primers
as described above. The radiolabeled primer was:
50-CCAAAAGGTTACCTCACGGG-30 complementary
to nucleotides 1435–1475 (E. coli numbering).
RESULTS
Mapping ofmodified nucleosides by LC/MS
Modiﬁed nucleosides were identiﬁed by LC/ESI-MS
analysis of the C. acetobutylicum 16S rRNA.
The chromatographic separation of a total nucleoside
digest is shown in Figure 1. The presence of nine diﬀerent
modiﬁed nucleosides in the 16S rRNA of
C. acetobutylicum is indicated,  ,D ,m
5C, Cm, m
7G,
m
3U, m
4Cm, m
2
2G and m
6
2A. Most of the assignments
could be derived from relative retention times and
correspondence of RICs for the protonated base and
nucleoside masses. For m
5C, m
4Cm and m
3U, speciﬁc
placement of the modiﬁcations on the base or
sugar residue was done based on LC/ESI-pseudo MS
3
comparison to standard samples (data not shown).
The absence of speciﬁc tRNA nucleosides (in particular
N
6-threonylcarbamoyl-adenosine) indicates that no tRNA
contamination is present (24).
The mass silent modiﬁcation pseudouridine ( ) was
not detected by LC/ESI-MS of the nucleosides digest and
Figure 1. HPLC chromatogram after total nucleoside digestion of
puriﬁed C. acetobutylicum 16S rRNA. UV trace at 260nm with
annotation of modiﬁed nucleosides and other components. (
 ) Are non-
nucleoside artefacts.
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Even with the method described in (14), no reliable
identiﬁcation was possible, probably because of the very
low concentration, short retention time on the reversed
phase column and higher number of fragment ions (25).
The structures of the modiﬁed nucleosides that
were characterized in this study can be viewed at
http://medlib.med.utah.edu/RNAmods (2).
The modiﬁed nucleosides depicted in Figure 1 were
mapped onto the 16S rRNA sequence by LC/ESI-MS
analysis of an RNase T1 digest of the intact puriﬁed 16S
rRNA. Comparison of the measured data to data
predicted from the gene sequence identiﬁed eight modiﬁed
oligonucleotides. These oligonucleotides and the m/z
values for modiﬁed monomers inside these oligonucleo-
tides are shown in Table 1. The modiﬁed monomers
are released during LC/ESI-MS/MS analysis with frag-
mentation in the collision cell, without precursor selection
in the quadrupole. This experimental setup allows
detection of the released modiﬁed bases and nucleotide
monomers at the same time as the molecular ion signals of
the oligonucleotides from which they originate. Figure 2
illustrates these experiments for the oligonucleotide
AAm
2
2Gm
5CAACGp. Exact sequence placement of
these modiﬁcations and of the sugar modiﬁcations
was done in a third step where fragmentation with
precursor selection was used to sequence the modiﬁed
oligonucleotides. Using sequencing software (23)
unambiguous mapping of the modiﬁcation in the
modiﬁcation containing oligonucleotides and thus in
the rRNA could be established (Figure 3).
Sequencing analysis by MS/MS of the oligonucleotide
UCACACCAUGp (mass: 3196.4), for sequence place-
ment of the extra methyl group, was problematic. Both
precursor ions with suﬃcient intensity for MS/MS
fragmentation (m/z values 1064.5 and 798.1) co-eluted
with other oligonucleotides with nearby m/z values
(e.g. the 30-terminal AUCACCUCCUUUCU, without
30 phosphate, with mass 4262.5 and m/z 1064.6 and the
oligonucleotide AUUAAUACCGp at pos. 155 with mass
3204.4 and m/z 800.9). The masses of the precursor
ions could not be selected separately without sacriﬁcing
sensitivity. Fortunately, m
5C blocks reverse transcription
and sequence location of this modiﬁcation could
be conﬁrmed by a reverse transcriptase assay (result
not shown).
Mapping of pseudouridine in the16SrRNA sequence
by CMC derivatization and reverse transcription
The phosphorimage of reversed transcriptase products
identifying  516 in C. acetobutylicum 16S rRNA is
depicted in Figure 4. This ﬁgure also shows a band
caused by m
7G, which is also important because of the
redundancy of the CCGCGp oligonucleotide produced
by RNase T1 (three occurrences). With the reversed
transcriptase technique,  30% of the 16S rRNA, contain-
ing the   modiﬁcation sites in other organisms (27), were
scanned. No other  s were detected in C. acetobutylicum.
DISCUSSION
Of the 11 post-transcriptionally modiﬁed nucleosides that
were reported in E. coli 16S rRNA, seven were also
detected in C. acetobutylicum 16S rRNA, while position
966 contains a m
2Gi nE. coli and a m
2
2Gi n
C. acetobutylicum. Interestingly, the same seven modiﬁca-
tions, and the m
2
2G at position 966, were recently
reported in the 16S rRNA of T. thermophilus (7),
indicating that these modiﬁcations are perhaps indispens-
able for the ribosomal biosynthesis or maturation. Indeed,
they are situated in or near helices 18, 31, 34, 44, 45
(Figure 5), which are functionally important sites in the
small subunit (SSU), where contacts to tRNA and the
large subunit (LSU) are made (1,29). This location would
allow them to directly inﬂuence these interactions or play
a role in the 3D folding of these important domains.
As shown in Table 2, three modiﬁcations in E. coli are
not present in C. acetobutylicum, while three modiﬁ-
cations in C. acetobutylicum are absent in E. coli.
Some of these diﬀerences are situated in helix 34 in
Table 1. Assignments of oligonucleotides from RNase T1 digestion of C. acetobutylicum 16S rRNA
Oligonucleotide Sequence
location
b
Mass
Calculated
c Measured Monomer
ions (m/z)
d
CCm
7GCG
a 525–529 1623.2 1637.1 164 [B-H]
 
AAm
2
2Gm
5CAACG
a 964–971 2634.4 2676.2 178, 124 [B-H]
 
UCmAAAUCAUCAUG
e 1194–1206 4147.5 4161.1 336 [Np-H]
 
CCCCUUAUG
f 1207–1215 2830.4 2832.4 307 [N4p-H]
 
m
4CmCCG 1402–1405 1278.2 1306.1 124 [B-H]
 
UCAm
5CACCAUG 1406–1415 3182.4 3196.1 318 [N4p-H]
 
m
5UAACAAG 1498–1504 2290.3 2304.2 125 [B-H]
 
m
6
2Am
6
2ACCUG 1518–1523 1937.3 1993.2 164 [B-H]
 
aUnmodiﬁed oligonucleotides contain guanosines and should have been hydrolyzed by RNase T1.
bSequence location utilizes E. coli numbering.
cPredicted, monoisotopic masses, calculated from the 16S rRNA gene sequence.
dm/z Values for monomers released in the collision cell at higher collision energy, [B-H]
 : base, [Np-H]
 : nucleoside phosphate, [N4p-H]
 :
nucleoside cyclic phosphate.
eCm1195 is identiﬁed by Pseudo MS
3 with fragmentation of N4p( m/z) 318.
fThe exact location of the dihydrouridine could not be determined, it is position 1211 or 1212.
3498 Nucleic Acids Research, 2007, Vol. 35, No. 10the head domain of the SSU. The Cm at position
1195 (E. coli numbering) in C. acetobutylicum is not
present in E. coli, although the base sequence is
nearly the same:...AGACGUCAAGUCA... in E. coli
and ...UGACGUCmAAAUCA...in C. acetobutylicum.
The m
2G modiﬁcation at position 1207 in E. coli is not
present in C. acetobutylicum, but this is not a surprise as
the primary sequence of the 16S rRNA is diﬀerent at this
position (C in C. acetobutylicum,Gi nE. coli). Helix 34
interacts with A site tRNA, but the inﬂuence of these
diﬀerences in modiﬁcation maps on ribosomal function is
unclear.
Our data also indicate the presence of a dihydrouridine
nucleoside at position 1211 or 1212, in between helices 32
and 34. However, both the LC/MS/MS data and RT
assays do not allow identiﬁcation of the exact location
site. This is the ﬁrst report on the presence of this
modiﬁcation in 16S rRNA, but further research is
necessary to conﬁrm the exact location of this modiﬁca-
tion and to determine its function.
Other diﬀerences are located in the 30 minor domain.
In helix 44 of E. coli 16S rRNA, a m
5C is present
at position 1407, while in C. acetobutylicum this modiﬁca-
tion is present at position 1409 (E. coli numbering).
Figure 2. HPLC-MS analysis of an RNase T1 hydrolysis mixture of
C. acetobutylicum 16S rRNA. Analysis was performed at 40eV collision
energy without precursor selection. (A, B, C and D) Reconstructed ion
chromatograms for the oligonucleotide AAGCAACGpþ3 methyl
groups, showing co-elution of signature ions for the intact oligonucleo-
tide and base ions for m
2
2G and m
5C. (E) UV trace at 260nm.
Figure 3. Product ion mass spectrum from CID of AAGCAACGpþ3
methyl groups (m/z 1337.2) at 45eV. Signature ion series are indicated
and place the modiﬁcations at AAm
2
2Gm
5CAACGp (for ion series
nomenclature see (26).
Figure 4. Phosphorimage of reverse transcriptase products of the
radiolabeled primer complementary to residues 548–569 (E. coli number-
ing). C, U, A and G indicate (dideoxy-)sequencing lanes, wt.þCMC:
CMC derivatized and alkali treated 16S rRNA puriﬁed from
C. acetobutylicum bacteria. wt. CMC: alkali treated 16S rRNA puriﬁed
from C. acetobutylicum bacteria. In vitro: T7 RNA polymerase
transcribed 16S rRNA from the cloned 16S rRNA gene. Arrows indicate
bands corresponding to modiﬁed nucleosides or secondary structure.
Nucleic Acids Research, 2007, Vol. 35,No. 10 3499Alignment of incomplete modiﬁcation maps of all organ-
isms in the SSU database indicates that both are rather
conserved modiﬁcation sites (5). Why these two adjacent
cytosines are so often modiﬁed is not known, both are
situated in the functionally important helix 44, at either
site of the bulged out A1406. G1516 in helix 45 of E. coli
16S rRNA, is methylated at position 2 of the base, while
C. acetobutylicum contains an unmodiﬁed A at this
position. Probably the purine at this position requires a
rather hydrophobic site at position 2. Again, no further
insight in the role of this modiﬁcation is known.
In general, the level of modiﬁcation appears to be
equal in E. coli and C. acetobutylicum 16S rRNA (each 11
modiﬁcation sites), while T. thermophilus 16S rRNA is
more extensively modiﬁed (14 modiﬁcation sites).
However, it appears that E. coli can only represent
mesophilic bacteria to a certain extent as some
C. acetobutylicum modiﬁcations are absent from E. coli
16S rRNA, while some E. coli modiﬁcations are absent
from C. acetobutylicum 16S rRNA.
The bacterial ribosomal SSU is a target for many
antibiotics. Both aminoglycoside (30) and cyclic peptide
antibiotics (31) target the top of helix 44 and tetracyclines
bind multiple sites in the SSU, e.g. helix 34. It has been
reported that some post-transcriptional modiﬁcations
alter the resistance to these ribosome-targeting antibiotics.
Therefore, knowledge of the natural modiﬁcation maps
might be interesting for the analysis of this type of
resistance mechanism. As C. acetobutylicum is an impor-
tant industrial bacterium, novel antibiotic resistance genes
might be used for plasmid maintenance during genetic
engineering. Furthermore, more information on this
resistance mechanism is also interesting from a therapeutic
point of view, because the Clostridium genus contains
several pathogenic species. The inﬂuence of post-
transcriptional modiﬁcations on the sensitivity to amino-
glycosides has been the best studied, however, anaerobic
Clostridium species are resistant to these antibiotics
because they lack active membrane transport.
Furthermore, resistance to the cyclic peptide antibiotics
(capreomycin and viomycin) has been reported to be
caused by the loss of a 20-O-methyl group from C1409
(E. coli numbering) in Mycobacteria (31), other species
without this modiﬁcation (e.g. E. coli) are less sensitive.
Figure 5. Secondary structure from bacterial 16S rRNA, important
helices are numbered (28).
Table 2. Comparison of modiﬁcations in 16S rRNA of C. acetobutylicum with E. coli and T. thermophilus
Pos.
a E. coli C. acetobutylicum T. Thermophilus
516 Pseudouridine (c) Pseudouridine (c) Pseudouridine (c)
527 7-methylguanosine (m
7G) 7-methylguanosine (m
7G) 7-methylguanosine (m
7G)
966 N
2-methylguanosine (m
2G) N
2,N
2-dimethylguanosine (m
2
2G) N
2,N
2-dimethylguanosine (m
2
2G)
967 5-methylcytidine (m
5C) 5-methylcytidine (m
5C) 5-methylcytidine (m
5C)
1195 no modiﬁcation present 20-O-dimethylcytidine (Cm) No modiﬁcation present
1207 N
2-methylguanosine (m
2G) No modiﬁcation present N
2-methylguanosine (m
2G)
X
b no modiﬁcation present Dihydrouridine No modiﬁcation present
1400 no modiﬁcation present No modiﬁcation present 5-methylcytidine (m
5C)
1402 N
4,20-O-dimethylcytidine (m
4Cm) N
4,20-O-dimethylcytidine (m
4Cm) N
4,20-O-dimethylcytidine (m
4Cm)
1404 no modiﬁcation present No modiﬁcation present 5-methylcytidine (m
5C)
1407 5-methylcytidine (m
5C) No modiﬁcation present 5-methylcytidine (m
5C)
1409 no modiﬁcation present 5-methylcytidine (m
5C) No modiﬁcation present
1498 3-methyluridine (m
3U) 3-methyluridine (m
3U) 3-methyluridine (m
3U)
1516 N
2-methylguanosine (m
2G) No modiﬁcation present No modiﬁcation present
1518 N
6,N
6-dimethyladenosine (m
6
2A) N
6,N
6-dimethyladenosine (m
6
2A) N
6,N
6-dimethyladenosine (m
6
2A)
1519 N
6,N
6-dimethyladenosine (m
6
2A) N
6,N
6-dimethyladenosine (m
6
2A) N
6,N
6-dimethyladenosine (m
6
2A)
1540 no modiﬁcation present No modiﬁcation present Pseudouridine
1541 no modiﬁcation present No modiﬁcation present Pseudouridine
aSequence position utilizes E. coli numbering.
bX: 1211 or 1212.
3500 Nucleic Acids Research, 2007, Vol. 35, No. 10The inﬂuence of the 5-methylation of C1409 in
C. acetobutylicum or the loss of this methylation on the
sensitivity to capreomycin or viomycin remains to be
studied. Clostridium acetobutylicum is sensitive
to tetracyclines, but no links between resistance to
these antibiotics and rRNA methylation has been reported
yet (30).
The results for C. acetobutylicum were compared to the
T1 catalog data, detected by Tanner et al. (32) and
compiled in the SSU database (5) These short sequences
were used in early studies to establish patterns of
phylogenetic relatedness. Although C. acetobutylicum
itself was not determined, good correspondence was
found with the other gram-positive anaerobic species
(Table 3). Not surprisingly, the best correspondence was
found with C. butyricum, phylogenetically closest to
C. acetobutylicum.
During the last decade, several methods have
been published that use MS for the analysis of post-
transcriptional modiﬁcations (33–36). Quadrupole
instruments are very popular because of the ﬂexibility
of their scan functions. Unfortunately, some of these
scan functions are not available on a oa-qTof instru-
ment. On the other hand, to determine the nature of
modiﬁed bases in an oligonucleotide, the oa-qTof
allows the use of a diﬀerent scan function from the
quadrupole scan functions. In quadrupole instruments,
an increased cone voltage is applied to release modiﬁed
bases or nucleotides from the oligonucleotides. Careful
time alignment of chromatic proﬁles of runs with and
without increased cone voltages is needed to identify
modiﬁed oligonucleotides from which the modiﬁed
bases or fragments originated. In contrast, in oa-qTof
instruments, the release of these fragments can be
initiated by increasing the collision voltage in the
collision cell, thus producing monomer ions, which are
measured in the TOF analyzer. The broad mass range
of the TOF analyzer allows the simultaneous detection
of the small base ions (m/z 100–150) and the large
oligonucleotide molecular ions (m/z 500–1500) from
which the base ions originate. With this diﬀerent
method of collision cell fragmentation without
precursor selection, time alignment of chromatographic
proﬁles is no longer necessary and nearly unambiguous
connection of modiﬁed base ions and modiﬁcation
containing oligonucleotides is possible. It is another
extension of the already wide variety of MS
based methods for the analysis of post-transcriptional
modiﬁcations in large RNAs. In source fragmentation
instead of collision cell fragmentation is not an
option on the oa-qTof, because the quadrupole ﬁlter,
even when used in rf-only mode, restricts the transmis-
sion of a wide m/z range. This makes it impossible
to simultaneously detect base and oligonucleotide
anions.
Although LC/ESI-MS is extremely powerful in
the analysis of post-transcriptional modiﬁcations,
it seems that in some cases the combination with reverse
transcriptase assays is necessary. For example, if both
RNase T1 and RNase A digests produce redundant
oligonucleotides (e.g. CCGCGp) or when MS/MS
sequencing is problematic because of co-eluting
oligonucleotides with the same m/z values (e.g. m/z
1064.5 for UCACACCAUGp, z¼ 3, and the 30 terminal
oligonucleotide AUCACCUCCUUUCU, without 30
phosphate with m/z 1064.6 and z¼ 4). As was illustrated
in this study for the oligonucleotide CCm
7GCGp, reverse
transcriptase is stopped at base modiﬁed nucleosides and,
although exact identiﬁcation of the modiﬁcation is not
possible, it can be used to discriminate redundant
modiﬁed oligonucleotides, when comparison to data
predicted from the gene sequence can not reveal the
exact location of the modiﬁcation.
Furthermore, analysis of pseudouridine by LC/MS is
not straightforward because it is isobaric to uridine.
Given the fact that the only known pseudouridylation
site in Bacillus subtilis and E. coli 16S rRNA is present
at position 516 (E. coli numbering) (37) and given the
great correspondence between modiﬁcations in E. coli
and modiﬁcations found in C. acetobutylicum,   was
expected to be present at position 516 in C. acetobuty-
licum 16S rRNA as well. Therefore, all methods based on
preliminary RNase T1 digestion can not be used as they
will produce 35 UG isomers from the C. acetobutylicum
16S rRNA. Pomerantz and McCloskey propose in this
case to replace RNase T1 by nuclease U2, but this
enzyme is no longer commercially available. We have
chosen the approach described by Bakin and Ofengand
(18): All U-like and G-like residues were derivatized with
CMC followed by an alkaline removal of all CMC
groups except those linked to the N3 of  . CMC
derivatized   blocks the reverse transcription reaction of
radiolabeled primers, highlighting the position of the  
on a PAGE gel.
For both the analysis of pseudouridine and other
modiﬁcations by reverse transcription assays, comparison
of wild-type 16S rRNA to in vitro produced 16S rRNA
Table 3. SSU database modiﬁcations list for the gram-positive anae-
robes listed
Gram-positive anaerobes
1: Clostridium barkeri,2 :Eubacterium limosum,
3: Acetobacterium woodii,4 :Clostridium lituseburense,
5: Eubacterium tenue,6 :Clostridium butyricum
Oligonucleotide Species
aaG
a 1–5
AAg
b 1, 3–5
gCCG
a 1–6
CCgCG
c 1–6
cAACG
b 1–6
AuUAG
a 1–6
aaCCUG
c 6
uAACAAG
c 1–6
UACACA(c,C)G
a 1–3
CCCC(u,U)AUG
a 6
UCAcACCACG
a 1–4
UCAcACCAUG
c 5, 6
UcAAAUCAUCAUG
c 3–6
Predicted modiﬁed nucleosides are in bold and small caps.
aWere not detected in the C. acetobutylicum samples.
bWere detected as the oligonucleotide AAGCAACG (see Table 1).
cWere detected in the C. acetobutylicum samples.
Nucleic Acids Research, 2007, Vol. 35,No. 10 3501is necessary to diﬀerentiate between bands on the gel that
are caused by secondary structure of the 16S rRNA
and bands that are caused by post-transcriptional
modiﬁcations. Thus unambiguous identiﬁcation of
modiﬁcation sites is possible.
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